Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Immunity
|
January 5, 2022
Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor types
Aparna Chhibber, Lingkang Huang, Hong Zhang, et al.
Journal for Immunotherapy of Cancer
|
February 1, 2022
Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors
Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, et al.
Gynecologic Oncology
|
June 25, 2026
Technical evaluation of commercially available homologous recombination deficiency assays using MyChoice CDx as reference in ovarian cancer
Alexander Yarunin, Ping Qiu, Xiaodun Li, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2022
Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study
Irene M Shui, Xiao Qiao Liu, Qing Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2018
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho, Hae Su Kim, Bo Mi Ku, et al.
Oncoimmunology
|
September 18, 2018
Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer
Song Ee Park, Kyunghee Park, Eunjin Lee, et al.
Journal of Cellular and Molecular Medicine
|
August 27, 2019
Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model
Haiyan Xu, Eric S Muise, Sarah Javaid, et al.
JCO Precision Oncology
|
March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Nature Communications
|
January 9, 2016
Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination
Slim Fourati, Razvan Cristescu, Andrey Loboda, et al.
Molecular Cancer Therapeutics
|
March 18, 2016
An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies
Jennifer O'Neil, Yair Benita, Igor Feldman, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Immunity
|
January 5, 2022
Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor types
Aparna Chhibber, Lingkang Huang, Hong Zhang, et al.
Journal for Immunotherapy of Cancer
|
February 1, 2022
Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors
Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, et al.
Gynecologic Oncology
|
June 25, 2026
Technical evaluation of commercially available homologous recombination deficiency assays using MyChoice CDx as reference in ovarian cancer
Alexander Yarunin, Ping Qiu, Xiaodun Li, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2022
Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study
Irene M Shui, Xiao Qiao Liu, Qing Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2018
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho, Hae Su Kim, Bo Mi Ku, et al.
Oncoimmunology
|
September 18, 2018
Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer
Song Ee Park, Kyunghee Park, Eunjin Lee, et al.
Journal of Cellular and Molecular Medicine
|
August 27, 2019
Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model
Haiyan Xu, Eric S Muise, Sarah Javaid, et al.
JCO Precision Oncology
|
March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Nature Communications
|
January 9, 2016
Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination
Slim Fourati, Razvan Cristescu, Andrey Loboda, et al.
Molecular Cancer Therapeutics
|
March 18, 2016
An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies
Jennifer O'Neil, Yair Benita, Igor Feldman, et al.
Page
of 6